Octaarginine-modified liposomes: Enhanced cellular uptake and controlled intracellular trafficking

International Journal of Pharmaceutics

Volumn 354, Issue 1-2, 2008, Pages 39-48

  Khalil, Ikramy A ^a,c   Kogure, Kentaro ^b,c   Futaki, Shiroh ^d   Harashima, Hideyoshi ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Endocytosis; Gene delivery; Intracellular trafficking; Liposomes; Octaarginine

Indexed keywords

AMILORIDE; ARGININE; CLATHRIN; CYTOCHALASIN D; GENISTEIN; LIPOFECTAMINE; LIPOSOME; METHYL BETA CYCLODEXTRIN; NUCLEIC ACID; NYSTATIN; OCTAARGININE; OLIGOARGININE DERIVATIVE; PENETRATIN; PEPTIDE; UNCLASSIFIED DRUG; VIRUS VECTOR;

CELL MIGRATION; DRUG DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; PRIORITY JOURNAL; SHORT SURVEY;

BIOLOGICAL TRANSPORT; CLATHRIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LIPOSOMES; NANOPARTICLES; OLIGOPEPTIDES; PROTEIN TRANSPORT;

EID: 40849140747     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.12.003     Document Type: Short Survey

References (68)

1. Akita H., Ito R., Khalil I.A., Futaki S., and Harashima H. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol. Ther. 9 (2004) 443-451
2. Anderson R.G., Kamen B.A., Rothberg K.G., and Lacey S.W. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255 (1992) 410-411
3. Barka T., Gresik E.W., and van Der Noen H. Transduction of TAT-HA-beta-galactosidase fusion protein into salivary gland-derived cells and organ cultures of the developing gland, and into rat submandibular gland in vivo. J. Histochem. Cytochem. 48 (2000) 1453-1460
4. Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28 (2003) 145-151
5. Brooks H., Lebleu B., and Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 57 (2005) 559-577
6. Caron N.J., Torrente Y., Camirand G., Bujold M., Chapdelaine P., Leriche K., Bresolin N., and Tremblay J.P. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol. Ther. 3 (2001) 310-318
7. Caron N.J., Quenneville S.P., and Tremblay J.P. Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem. Biophys. Res. Commun. 319 (2004) 12-20
8. Cryan S.A., Devocelle M., Moran P.J., Hickey A.J., and Kelly J.G. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation. Mol. Pharm. 3 (2006) 104-112
9. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., and Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271 (1996) 18188-18193
10. Derossi D., Chassaing G., and Prochiantz A. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8 (1998) 84-87
11. Dietz G.P., and Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell Neurosci. 27 (2004) 85-131
12. Drin G., Mazel M., Clair P., Mathieu D., Kaczorek M., and Temsamani J. Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur. J. Biochem. 268 (2001) 1304-1314
13. Eguchi A., Akuta T., Okuyama H., Senda T., Yokoi H., Inokuchi H., Fujita S., Hayakawa T., Takeda K., Hasegawa M., and Nakanishi M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276 (2001) 26204-26210
14. Elouahabi A., and Ruysschaert J.M. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. 11 (2005) 336-347
15. Farhood H., Serbina N., and Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235 (1995) 289-295
16. Ferrari A., Pellegrini V., Arcangeli C., Fittipaldi A., Giacca M., and Beltram F. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8 (2003) 284-294
17. Fischer R., Kohler K., Fotin-Mleczek M., and Brock R. A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279 (2004) 12625-12635
18. Fittipaldi A., Ferrari A., Zoppe M., Arcangeli C., Pellegrini V., Beltram F., and Giacca M. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278 (2003) 34141-34149
19. Foerg C., Ziegler U., Fernandez-Carneado J., Giralt E., Rennert R., Beck-Sickinger A.G., and Merkle H.P. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44 (2005) 72-81
20. Fretz M.M., Koning G.A., Mastrobattista E., Jiskoot W., and Storm G. OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochim. Biophys. Acta 1665 (2004) 48-56
21. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
22. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., Harashima H., and Sugiura Y. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug. Chem. 12 (2001) 1005-1011
23. Futaki S., Niwa M., Nakase I., Tadokoro A., Zhang Y., Nagaoka M., Wakako N., and Sugiura Y. Arginine carrier peptide bearing Ni(II) chelator to promote cellular uptake of histidine-tagged proteins. Bioconjug. Chem. 15 (2004) 475-481
24. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Deliv. Rev. 57 (2005) 547-558
25. Gupta B., Levchenko T.S., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57 (2005) 637-651
26. Hyndman L., Lemoine J.L., Huang L., Porteous D.J., Boyd A.C., and Nan X. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Control. Release 99 (2004) 435-444
27. Iwasa A., Akita H., Khalil I., Kogure K., Futaki S., and Harashima H. Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. Biochim. Biophys. Acta 1758 (2006) 713-720
28. Jarver P., and Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today 9 (2004) 395-402
29. Kakudo T., Chaki S., Futaki S., Nakase I., Akaji K., Kawakami T., Maruyama K., Kamiya H., and Harashima H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 43 (2004) 5618-5628
30. Kaplan I.M., Wadia J.S., and Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Release 102 (2005) 247-253
31. Khalil I.A., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., and Harashima H. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther. 11 (2004) 636-644
32. Khalil I.A., Kogure K., Akita H., and Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58 (2006) 32-45
33. Khalil I.A., Kogure K., Futaki S., and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281 (2006) 3544-3551
34. Khalil I.A., Kogure K., Futaki S., Hama S., Akita H., Ueno M., Kishida H., Kudoh M., Mishina Y., Kataoka K., Yamada M., and Harashima H. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther. 14 (2007) 682-689
35. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., and Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J. Control. Release 98 (2004) 317-323
36. Lamaze C., and Schmid S.L. The emergence of clathrin-independent pinocytic pathways. Curr. Opin. Cell Biol. 7 (1995) 573-580
37. Lasic D.D., and Papahadjopoulos D. Liposomes and biopolymers in drug and gene delivery. Curr. Opin. Solid State Mater. Sci. 1 (1996) 392-400
38. Lasic D.D., and Templeton N.S. Liposomes in gene therapy. Adv. Drug Deliv. Rev. 20 (1996) 221-266
39. Lasic D.D. Novel applications of liposomes. Trends Biotechnol. 16 (1998) 307-321
40. Lindgren M., Hallbrink M., Prochiantz A., and Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21 (2000) 99-103
41. Marty C., Meylan C., Schott H., Ballmer-Hofer K., and Schwendener R.A. Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes. Cell Mol. Life Sci. 61 (2004) 1785-1794
42. Meier O., Boucke K., Hammer S.V., Keller S., Stidwill R.P., Hemmi S., and Greber U.F. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158 (2002) 1119-1131
43. Mounkes L.C., Zhong W., Cipres-Palacin G., Heath T.D., and Debs R.J. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. 273 (1998) 26164-26170
44. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., Takehashi M., Tanaka S., Ueda K., Simpson J.C., Jones A.T., Sugiura Y., and Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10 (2004) 1011-1022
45. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
46. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., and Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280 (2005) 15300-15306
47. Rudolph C., Plank C., Lausier J., Schillinger U., Muller R.H., and Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278 (2003) 11411-11418
48. Ruponen M., Yla-Herttuala S., and Urtti A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim. Biophys. Acta 1415 (1999) 331-341
49. Saalik P., Elmquist A., Hansen M., Padari K., Saar K., Viht K., Langel U., and Pooga M. Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug. Chem. 15 (2004) 1246-1253
50. Schmid S.L. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu. Rev. Biochem. 66 (1997) 511-548
51. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
52. Schwarze S.R., Hruska K.A., and Dowdy S.F. Protein transduction: unrestricted delivery into all cells?. Trends Cell Biol. 10 (2000) 290-295
53. Snyder E.L., and Dowdy S.F. Cell penetrating peptides in drug delivery. Pharm. Res. 21 (2004) 389-393
54. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., and Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277 (2002) 2437-2443
55. Swanson J.A., and Watts C. Macropinocytosis. Trends Cell Biol. 5 (1995) 424-428
56. Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8786-8791
57. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., and D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1972-1977
58. Trehin R., and Merkle H.P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 58 (2004) 209-223
59. Tseng Y.L., Liu J.J., and Hong R.L. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol. Pharmacol. 62 (2002) 864-872
60. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276 (2001) 3254-3261
61. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
62. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
63. Wasungu L., and Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J. Control. Release 116 (2006) 255-264
64. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13003-13008
65. Yoneda A., and Couchman J.R. Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol. 22 (2003) 25-33
66. Zaro J.L., and Shen W.C. Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells. J. Control. Release 108 (2005) 409-417
67. Zuhorn I.S., Bakowsky U., Polushkin E., Visser W.H., Stuart M.C., Engberts J.B., and Hoekstra D. Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol. Ther. 11 (2005) 801-810
68. Zuhorn I.S., Kalicharan D., Robillard G.T., and Hoekstra D. Adhesion receptors mediate efficient non-viral gene delivery. Mol. Ther. 15 (2007) 946-953